These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 7923152

  • 1. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.
    Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM.
    Cancer Res; 1994 Oct 15; 54(20):5269-72. PubMed ID: 7923152
    [Abstract] [Full Text] [Related]

  • 2. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N, Bressac-de Paillerets B, Desjardins L, Lévy C, Bombled J, Gorin I, Schlienger P, Stoppa-Lyonnet D.
    Br J Cancer; 2000 Feb 15; 82(4):818-22. PubMed ID: 10732752
    [Abstract] [Full Text] [Related]

  • 3. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M, Berd D, Shimizu M, Nagai H, Cotticelli M-G, Mastrangelo M, Shields JA, Shields CL, Croce CM, Huebner K.
    Int J Cancer; 1996 Mar 15; 65(6):762-7. PubMed ID: 8631588
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
    Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J.
    Nat Genet; 1994 Sep 15; 8(1):23-6. PubMed ID: 7987388
    [Abstract] [Full Text] [Related]

  • 5. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.
    Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y.
    Cancer Res; 1994 Jul 01; 54(13):3396-7. PubMed ID: 8012957
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 01; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 7. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
    Glendening JM, Flores JF, Walker GJ, Stone S, Albino AP, Fountain JW.
    Cancer Res; 1995 Dec 01; 55(23):5531-5. PubMed ID: 7585628
    [Abstract] [Full Text] [Related]

  • 8. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.
    Cancer Res; 2000 Dec 15; 60(24):6864-7. PubMed ID: 11156381
    [Abstract] [Full Text] [Related]

  • 9. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
    Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI.
    Cancer Res; 1995 Mar 01; 55(5):984-8. PubMed ID: 7867008
    [Abstract] [Full Text] [Related]

  • 10. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
    Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK.
    Oncogene; 1995 Mar 16; 10(6):1061-7. PubMed ID: 7700630
    [Abstract] [Full Text] [Related]

  • 11. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Reed JA, Loganzo F, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW.
    Cancer Res; 1995 Jul 01; 55(13):2713-8. PubMed ID: 7796391
    [Abstract] [Full Text] [Related]

  • 12. Mutations associated with familial melanoma impair p16INK4 function.
    Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC.
    Nat Genet; 1995 May 01; 10(1):114-6. PubMed ID: 7647780
    [Abstract] [Full Text] [Related]

  • 13. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW.
    Cancer Res; 1996 Nov 01; 56(21):5023-32. PubMed ID: 8895759
    [Abstract] [Full Text] [Related]

  • 14. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL, Sidransky D.
    Invest Ophthalmol Vis Sci; 1999 Mar 01; 40(3):779-83. PubMed ID: 10067984
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma.
    Wang YL, Uhara H, Yamazaki Y, Nikaido T, Saida T.
    Br J Dermatol; 1996 Feb 01; 134(2):269-75. PubMed ID: 8746340
    [Abstract] [Full Text] [Related]

  • 16. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.
    Pollock PM, Yu F, Qiu L, Parsons PG, Hayward NK.
    Oncogene; 1995 Aug 17; 11(4):663-8. PubMed ID: 7651729
    [Abstract] [Full Text] [Related]

  • 17. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.
    Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D.
    Oncogene; 1995 Jul 20; 11(2):405-12. PubMed ID: 7624155
    [Abstract] [Full Text] [Related]

  • 18. CDKN2A mutation and deletion status in thin and thick primary melanoma.
    Cachia AR, Indsto JO, McLaren KM, Mann GJ, Arends MJ.
    Clin Cancer Res; 2000 Sep 20; 6(9):3511-5. PubMed ID: 10999737
    [Abstract] [Full Text] [Related]

  • 19. Lack of germline CDK6 mutations in familial melanoma.
    Shennan MG, Badin AC, Walsh S, Summers A, From L, McKenzie M, Goldstein AM, Tucker MA, Hogg D, Lassam N.
    Oncogene; 2000 Mar 30; 19(14):1849-52. PubMed ID: 10777219
    [Abstract] [Full Text] [Related]

  • 20. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.
    Liu L, Goldstein AM, Tucker MA, Brill H, Gruis NA, Hogg D, Lassam NJ.
    Genes Chromosomes Cancer; 1997 May 30; 19(1):52-4. PubMed ID: 9135995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.